General Information of MET (ID: META00192)
Name Alpha-Lactose
Synonyms   Click to Show/Hide Synonyms of This Metabolite
(+)-Lactose; 1-beta-D-Galactopyranosyl-4-alpha-D-glucopyranose; 1-beta-delta-Galactopyranosyl-4-alpha-delta-glucopyranose; 4-O-Hexopyranosylhexose; 4-O-beta-D-Galactopyranosyl-alpha-D-glucopyranose; Aletobiose; Anhydrous lactose; Dilactose; Fast-flo lactose; Flowlac 100; GLC-(4-1)Gal; Galactinum; Granulac 140m; Lactin; Lactin (carbohydrate); Lactobiose; Lactohale 300; Lactose; Lactose anhydride; Lactose fast-flo; Lactose, anhydrous; Milk sugar; Osmolactan; Pharmatosa DCL 21; Pharmatose 21; Pharmatose 325m; Pharmatose DCL 15; Prismalac; Respitose ML 003; Respitose SV 003; Saccharum lactin; Sachelac; Sorbalac 400; Sorbolac 400; Spherolac; Super-tab; Tablettose; Tablettose 70; Tablettose 80; Zeparox ep; beta-D-Galp-(1->4)-alpha-D-GLCP
Source Endogenous;Escherichia Coli Metabolite;Food
Structure Type   Carbohydrates and carbohydrate conjugates  (Click to Show/Hide the Complete Structure Type Hierarchy)
Organic oxygen compounds
Organooxygen compounds
Carbohydrates and carbohydrate conjugates
PubChem CID
84571
HMDB ID
HMDB0000186
Formula
C12H22O11
Structure
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=84571"></iframe>
3D MOL 2D MOL
  Click to Show/Hide the Molecular/Functional Data (External Links/Property/Function) of This Metabolite
KEGG ID
C00243
ChEBI ID
36219
FooDB ID
FDB021789
ChemSpider ID
76293
METLIN ID
267
Physicochemical Properties Molecular Weight 342.3 Topological Polar Surface Area 190
XlogP -4.7 Complexity 382
Heavy Atom Count 23 Rotatable Bond Count 4
Hydrogen Bond Donor Count 8 Hydrogen Bond Acceptor Count 11
Function
alpha-Lactose is the major sugar present in milk and the main source of energy supplied to the newborn mammalian in its mother's milk. Lactose is also an important osmotic regulator of lactation. It is digested by the intestinal lactase (EC 3.2.1.108), an enzyme expressed in newborns. Its activity declines following weaning. As a result, adult mammals are normally lactose-intolerant and more than 75% of the human adult population suffers from lactase deficiency. Lactase deficiency is present in up to 80 percent of blacks and Latinos, and up to 100 percent of American Indians and Asians. Persons with lactose intolerance are unable to digest significant amounts of lactose. Common symptoms include abdominal pain and bloating, excessive flatus, and watery stool following the ingestion of foods containing lactose. A sizable number of adults believe they are lactose intolerant but do not actually have impaired lactose digestion, and some persons with lactase deficiency can tolerate moderate amounts of ingested lactose. A diagnosis of lactose intolerance can usually be made with a careful history supported by dietary manipulation. If necessary, diagnosis can be confirmed by using a breath hydrogen or lactose tolerance test. These mostly uncomfortable symptoms of lactose maldigestion are blamed for a variably dairy consumption. There is, however, emerging evidence that certain lactic acid-producing bacteria, which selectively consume prebiotics, may be beneficial against some lower intestinal diseases. Lactose maldigestion and lactose should perhaps be re-evaluated as a potential provider of such a prebiotic. Treatment consists primarily of avoiding lactose-containing foods. Lactase enzyme supplements may be helpful. The degree of lactose malabsorption varies greatly among patients with lactose intolerance, but most of them can ingest up to 350 mL of milk daily without symptoms. Lactose-intolerant patients must ensure adequate calcium intake. Lactose in the urine is a biomarker for the consumption of milk.
Regulatory Network
Full List of Protein(s) Regulating This Metabolite
      GPCR secretin (GPCR-2)
            Glucagon receptor (GCGR) Click to Show/Hide the Full List of Regulating Pair(s):   1 Pair(s)
               Detailed Information Protein   Info click to show the details of this protein
               Regulating Pair Experim Info click to show the details of experiment for validating this pair [1]
                      Introduced Variation Knockout of Gcgr
                      Induced Change Alpha-Lactose concentration: decrease (FC = 2)
                      Summary Introduced Variation         Induced Change 
                      Disease Status Type 2 diabetes mellitus [ICD-11: 5A11]
                      Details It is reported that knockout of GCGR leads to the decrease of alpha-Lactose levels compared with control group.
      Transferases (EC 2)
            Arylamine N-acetyltransferase 1 (NAT1) Click to Show/Hide the Full List of Regulating Pair(s):   1 Pair(s)
               Detailed Information Protein   Info click to show the details of this protein
               Regulating Pair Experim Info click to show the details of experiment for validating this pair [2]
                      Introduced Variation Knockout of NAT1
                      Induced Change Alpha-Lactose concentration: increase (FC = 26.4)
                      Summary Introduced Variation         Induced Change 
                      Disease Status Breast cancer [ICD-11: 2C60]
                      Details It is reported that knockout of NAT1 leads to the increase of alpha-Lactose levels compared with control group.
References
1 Polyomic profiling reveals significant hepatic metabolic alterations in glucagon-receptor (GCGR) knockout mice: implications on anti-glucagon therapies for diabetes. BMC Genomics. 2011 Jun 1;12:281.
2 CRISPR/Cas9 knockout of human arylamine N-acetyltransferase 1 in MDA-MB-231 breast cancer cells suggests a role in cellular metabolism. Sci Rep. 2020 Jun 17;10(1):9804.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.